Giltuss Bucalsep
NDC 58552-135, Benzocaine, Menthol, Zinc chloride, spray, from Gil Pharmaceutical Corp.
- Product NDC
- 58552-135
- Status
- Listed
- Labeler
- Gil Pharmaceutical Corp
- Dosage form
- SPRAY
- Route
- ORAL, TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58552-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZOCAINE6.5 g/100mL
- MENTHOL.1 g/100mL
- ZINC CHLORIDE.12 g/100mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58552-135-01 | 58552013501 | 1 BOTTLE, SPRAY in 1 CARTON (58552-135-01) / 30 mL in 1 BOTTLE, SPRAY |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58552-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58552-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58552-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.